Item 4 — Purpose of Transaction
Item 4 of this Schedule 13D is hereby amended and supplemented as follows: On February 27, 2026, the Issuer entered into a line of credit agreement (the "Line of Credit Agreement") with CorTer, under which CoreTer agreed to make an unsecured loan to the Issuer of up to $1,000,000 until February 27, 2027. Any loan amounts are prepayable by the Issuer without interest or penalty. On February 27, 2026, the Issuer also issued an unsecured promissory note to CoreTer (the "Note"), in the principal amount of the lesser of (i) $1,000,000,00 and (ii) the aggregate unpaid principal amount of all loans made pursuant to the Line of Credit Agreement, together with all accrued interest thereon. The Note bears interest at the rate of 8% per annum and matures on February 27, 2027. After the maturity date, CoreTer has the right to convert any outstanding principal and interest under the Note into shares of Common Stock at a conversion price equal to the weighted average closing price of the Common Stock for the twenty trading days prior to the conversion of the Note. The number of shares of Common Stock to which CoreTer may be entitled is subject to adjustments as a result of stock dividends, divisions, splits, combinations, reclassifications or certain corporate actions, as described in the Note. As a result of his ownership interest in and management of CoreTer, the Reporting Person may be deemed to be a member of a "group" (within the meaning of Rule 13d-5 under the Exchange Act) with CoreTer. As the Reporting Person is filing separately from CoreTer, the Reporting Person is responsible for the completeness and accuracy of the information concerning the Reporting Person contained herein but is not responsible for the completeness and accuracy of any information concerning other members of the group. The Reporting Person indirectly acquired 72,837,839 shares of Common Stock in connection with CoreTer's conversion of the Note and the Issuer's reimbursement of expenses paid by CoreTer. The information contained in Item 3 of this Schedule 13D is incorporated herein by reference. During the period from November 1, 2016 to May 8, 2026, Mr. Dockter gifted a total of 8,119,502 shares of Common Stock he owned to other individuals. The Reporting Person serves as the Chief Executive Officer, President and a director of the Issuer. Accordingly, the Reporting Person may have influence over the corporate activities of the Issuer, including activities that may relate to items described in clauses (a) through (j) of Item 4 of this Schedule 13D. The Reporting Person may, from time to time, purchase or sell securities of the Issuer as appropriate for his personal circumstances. Except as described in this Schedule 13D, the Reporting Person does not have any present plans or proposals that relate to or would result in any of the actions described in clauses (a) through (j) of Item 4 of this Schedule 13D. The Reporting Person reserves the right to formulate plans and/or proposals and to take such actions with respect to their investment in the Issuer, including any or all of the actions set forth in clauses (a) through (j) of Item 4 of this Schedule 13D.